LP-184 Rationale and design of two phase 3, Randomized, double-blind, placebo-controlled studies of the efficacy and safety of litifilimab in adults with active systemic lupus erythematosus: TOPAZ-1 and TOPAZ-2

Shranjeno v:
Bibliografske podrobnosti
izdano v:Lupus Science and Medicine
Main Authors: Richard A Furie, Kenneth Kalunian, Maria Dall’Era, Eric F Morand, Puja Joshi, Ting Wang, Xing Wei, Catherine Barbey, Ronald FVan Vollenhoven, Stacey Goode-sellers, George Kong, Youmna Lahoud
Format: Artigo
Izdano: BMJ Publishing Group 2023-07-01
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki